- Home
- IMMP vs GHG Comparison
IMMP vs GHG Comparison
Compare IMMP & GHG Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- IMMP
- GHG
- Stock Information
- Founded
- IMMP 1987
- GHG 2004
- Country
- IMMP Australia
- GHG China
- Employees
- IMMP N/A
- GHG N/A
- Industry
- IMMP Biotechnology: Pharmaceutical Preparations
- GHG Hotels/Resorts
- Sector
- IMMP Health Care
- GHG Consumer Discretionary
- Exchange
- IMMP Nasdaq
- GHG Nasdaq
- Market Cap
- IMMP 211.1M
- GHG 202.0M
- IPO Year
- IMMP N/A
- GHG 2018
- Fundamental
- Price
- IMMP $1.78
- GHG $2.12
- Analyst Decision
- IMMP Buy
- GHG
- Analyst Count
- IMMP 1
- GHG 0
- Target Price
- IMMP $7.00
- GHG N/A
- AVG Volume (30 Days)
- IMMP 150.7K
- GHG 22.0K
- Earning Date
- IMMP 02-27-2025
- GHG 06-24-2025
- Dividend Yield
- IMMP N/A
- GHG 4.06%
- EPS Growth
- IMMP N/A
- GHG N/A
- EPS
- IMMP N/A
- GHG 0.15
- Revenue
- IMMP $3,019,249.00
- GHG $184,055,595.00
- Revenue This Year
- IMMP $50.37
- GHG $19.02
- Revenue Next Year
- IMMP N/A
- GHG $8.26
- P/E Ratio
- IMMP N/A
- GHG $14.08
- Revenue Growth
- IMMP 24.11
- GHG N/A
- 52 Week Low
- IMMP $1.32
- GHG $1.95
- 52 Week High
- IMMP $2.86
- GHG $3.40
- Technical
- Relative Strength Index (RSI)
- IMMP 44.44
- GHG 55.37
- Support Level
- IMMP $1.88
- GHG $1.96
- Resistance Level
- IMMP $1.94
- GHG $2.04
- Average True Range (ATR)
- IMMP 0.12
- GHG 0.05
- MACD
- IMMP -0.03
- GHG 0.02
- Stochastic Oscillator
- IMMP 0.00
- GHG 100.00
About IMMP Immutep Limited
Immutep Ltd is a globally active biotechnology company developing immunotherapy products for cancer and autoimmune diseases. Its main product is IMP321, which involves clinical development for the treatment of cancer indications. The company is also focused on the development of other products, which include IMP701, which is a blocking anti-LAG-3 antibody for cancer and is in Phase I of its clinical trials, and CVac, which is a personalized immunocellular therapeutic investigated for the treatment of epithelial cancer. Geographically all the business activity of the firm is functioned through the region of Australia.
About GHG GreenTree Hospitality Group Ltd. American depositary shares each representing one ordinary share
GreenTree Hospitality Group Ltd is a franchised hotel operator in China as franchised and managed hotels represent almost all the hotels in its hotel network. The hotel network of the company comprised approximately 4,059 hotels with nearly 302,497 rooms in China, covering all centrally administrated municipalities and cities throughout all provinces and autonomous regions in China. The company operates its hotels under GreenTree Inns, GreenTree Eastern, Gme, Gya and VX, GreenTree Alliance, Vatica, and others. The company operates solely in China and generates all its revenue from China itself.